Medicine to be voluntarily withdrawn from the market by the company LONDON, 06-Mar-2018 — /EuropaWire/ — The European Medicines Agency (EMA) has started an urgent review of the multiple sclerosis medicine Zinbryta (daclizumab) following 7 cases of serious inflammatory brain disorders … Read the full press release
The 2018 IUPAC-Richter Prize in Medicinal Chemistry has been awarded to Peter D.J. Grootenhuis. BUDAPEST, 30-Jan-2018 — /EuropaWire/ — Peter D.J. Grootenhuis received this award in recognition of his outstanding creative contributions to the invention, discovery, and development of the medicine … Read the full press release
Posted in Awards, Healthcare, Hungary, Pharma & Biotech
Tagged 2018 IUPAC-Richter Prize, Award, chemistry, Cystic Fibrosis, Medicinal Chemistry, medicine, Peter D.J. Grootenhuis
Bayer foundation scholarships – EUR 200,000 for work and study abroad Support for ambitious study projects in the fields of science, engineering, medicine and teacher training in scientific subjects / Hermann Strenger scholarships to sponsor career-training projects abroad Leverkusen, 5-6-2013 … Read the full press release
Posted in Chemicals, Education, Financial, Germany, Non Profit, Pharma & Biotech, Science, Society
Tagged Bayer, Bayer foundation scholarships, Bayer Science & Education Foundation, Biochemistry, biology, biometrics, bioprocess engineering, biotechnology, career-training projects abroad, Carl Duisberg scholarship, chemical engineering, chemistry, engineering, Foundation, Hermann Strenger scholarships, Kurt Hansen scholarship, Leverkusen, medicine, Otto Bayer scholarship, pharmacy, physics, scholarships, science, Statistics, study projects, teacher training
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?